AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12709818 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone-17-valerate
Number of subjects: 21
Study 12709818 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 21
Study 10595626 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 266
Study 10595626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 266
Study 7480986 — intervention group
Group type: EXPERIMENTAL
Intervention: b.d. regimen (twice daily)
Number of subjects: 58
Study 7480986 — intervention group
Group type: COMPARATOR
Intervention: q.d. regimen (four times a day)
Number of subjects: 58
Study 2025036 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine iron supplementation
Number of subjects: 2912
Study 2025036 — intervention group
Group type: COMPARATOR
Intervention: Non-routine iron supplementation
Number of subjects: 2912
Study 2025036 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 2912
Study 2025036 — intervention group
Group type: EXPERIMENTAL
Intervention: High ratio for packed cell volume
Number of subjects: 2912
Study 7402802 — intervention group
Group type: EXPERIMENTAL
Intervention: Rooming-in
Number of subjects: 301
Study 7402802 — intervention group
Group type: COMPARATOR
Intervention: Control (routine postpartum contact)
Number of subjects: 301
Study 31401726 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent inguinal hernia repair
Number of subjects: 134391
Study 31401726 — intervention group
Group type: COMPARATOR
Intervention: Primary inguinal hernia repair
Number of subjects: 134391
Study 30919492 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebamipide (300 mg/day)
Number of subjects: 83
Study 30919492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 27836677 — intervention group
Group type: EXPERIMENTAL
Intervention: NEMEX therapy (neuro-muscular exercise) twice a week for 8 weeks
Number of subjects: 93
Study 27836677 — intervention group
Group type: COMPARATOR
Intervention: PHARMA (instructions in optimized analgesics and anti-inflammatory drug use)
Number of subjects: 93
Study 27836677 — intervention group
Group type: EXPERIMENTAL
Intervention: NEMEX therapy
Number of subjects: 93
Study 27836677 — intervention group
Group type: COMPARATOR
Intervention: PHARMA
Number of subjects: 93
Study 27836677 — intervention group
Group type: COMPARATOR
Intervention: NEMEX therapy and PHARMA
Number of subjects: 93
Study 25831993 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric training at long muscle length (LL)
Number of subjects: 16
Study 25831993 — intervention group
Group type: COMPARATOR
Intervention: Isometric training at short muscle length (SL)
Number of subjects: 16
Study 25831993 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LL and SL)
Number of subjects: 16
Study 23415779 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical cyclosporine A 0.05% emulsion twice daily for 3 months postoperatively
Number of subjects: 124
Study 23415779 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative treatment regimen without topical cyclosporine A
Number of subjects: 124
Study 21097795 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide via Turbuhaler (TBH), twice daily
Number of subjects: 115
Study 19154960 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamin E, 800 IU; vitamin C, 500 mg; beta-carotene, 10 mg)
Number of subjects: 48
Study 19154960 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 48
Study 16776335 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma knife surgery to the retrogasserian cisternal portion of the fifth cranial nerve, median dose 85 Gy (range 70‐90 Gy)
Number of subjects: 100
Study 16776335 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma knife surgery
Number of subjects: 100
Study 15788983 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligomineral water (1.5 liters daily for 4 weeks)
Number of subjects: 24
Study 15788983 — intervention group
Group type: COMPARATOR
Intervention: Tap water (1.5 liters daily for 4 weeks)
Number of subjects: 24
Study 11316215 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg p.o. b.i.d. for 3 months
Number of subjects: 22
Study 11316215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9135355 — intervention group
Group type: EXPERIMENTAL
Intervention: i.m. lignocaine
Number of subjects: 90
Study 9135355 — intervention group
Group type: EXPERIMENTAL
Intervention: i.m. bupivacaine
Number of subjects: 90
Study 9135355 — intervention group
Group type: COMPARATOR
Intervention: i.v. propofol
Number of subjects: 90
Study 7895895 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg low-molecular-weight dermatan sulphate
Number of subjects: 16
Study 7895895 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg low-molecular-weight dermatan sulphate
Number of subjects: 16
Study 7895895 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg and 200 mg low-molecular-weight dermatan sulphate
Number of subjects: 16
Study 3313232 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 383
Study 3313232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 383
Study 31462489 — intervention group
Group type: EXPERIMENTAL
Intervention: six-session VR cognitive treatment added to treatment as usual
Number of subjects: 432
Study 31462489 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual alone
Number of subjects: 432
Study 28008080 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 min of 10Hz rTMS stimulation (1500 pulses) at 110% of the individual motor threshold
Number of subjects: 23
Study 28008080 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study 25974049 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity functional exercise program (intensive strengthening and balance exercises in small groups twice a week for 12 weeks)
Number of subjects: 170
Study 25974049 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity functional exercise program
Number of subjects: 170
Study 25974049 — intervention group
Group type: COMPARATOR
Intervention: Leisure activities (control group)
Number of subjects: 170
Study 23765237 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 100
Study 23765237 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive mechanical ventilation (IMV)
Number of subjects: 100
Study 23765237 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal replacement therapy after invasive mechanical ventilation (RRT after IMV)
Number of subjects: 100
Study 23765237 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of patient preferences
Number of subjects: 100
Study 23765237 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional bed availability
Number of subjects: 100
Study 21557648 — intervention group
Group type: EXPERIMENTAL
Intervention: Part-task condition
Number of subjects: 0
Study 21557648 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-task condition
Number of subjects: 0
Study 21557648 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual differences in learning gains
Number of subjects: 0
Study 17957221 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 20
Study 17957221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 17139955 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery for colon cancer
Number of subjects: 0
Study 17139955 — intervention group
Group type: COMPARATOR
Intervention: Open surgical resection of the primary tumor
Number of subjects: 0
Study 14731181 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical Guided Bone Regeneration (GBR) with autogenous bone and e-PTFE membranes; 25 implants placed.
Number of subjects: 21
Study 14731181 — intervention group
Group type: COMPARATOR
Intervention: Distraction Osteogenesis (DO); 34 implants placed.
Number of subjects: 21
Study 11269565 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 2
Study 9425679 — intervention group
Group type: EXPERIMENTAL
Intervention: Splay texture
Number of subjects: 0
Study 9425679 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression texture
Number of subjects: 0
Study 9425679 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 8431592 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthoplast cock-up splint
Number of subjects: 12
Study 8431592 — intervention group
Group type: COMPARATOR
Intervention: Ready-made Camp Droitwich splint
Number of subjects: 12
Study 8431592 — intervention group
Group type: EXPERIMENTAL
Intervention: Both splints
Number of subjects: 12
Study 3318450 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 6000000
Study 3318450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6000000
Study 28671504 — intervention group
Group type: EXPERIMENTAL
Intervention: Amsterdam Cognition Scan (ACS)
Number of subjects: 201
Study 28671504 — intervention group
Group type: COMPARATOR
Intervention: Traditional neuropsychological test battery
Number of subjects: 201
Study 28671504 — intervention group
Group type: COMPARATOR
Intervention: Visuospatial memory test (part of traditional battery)
Number of subjects: 201
Study 27994394 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive tipped (OT) cannula
Number of subjects: 120
Study 27994394 — intervention group
Group type: COMPARATOR
Intervention: Conventional Steven's cannula (ST)
Number of subjects: 120
Study 24077863 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched intervention targeting specific psychological profile
Number of subjects: 105
Study 24077863 — intervention group
Group type: COMPARATOR
Intervention: Unmatched intervention
Number of subjects: 105
Study 22624990 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent
Number of subjects: 1052
Study 22624990 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting stent
Number of subjects: 1052
Study 20838059 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy
Number of subjects: 38
Study 18655559 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuichan Zhusheng Decoction (CZD), 300 mL daily, taken orally for 3 days
Number of subjects: 90
Study 18655559 — intervention group
Group type: COMPARATOR
Intervention: Pitocin, 1 U into 500 mL 5% glucose for intravenous dripping for 3 days
Number of subjects: 90
Study 18655559 — intervention group
Group type: COMPARATOR
Intervention: Placebo of CZD, administrated in the same way as treated group
Number of subjects: 90
Study 15722401 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 10 mg
Number of subjects: 15
Study 15722401 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 15
Study 15722401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 15722401 — intervention group
Group type: COMPARATOR
Intervention: Temazepam (10 mg)
Number of subjects: 15
Study 15722401 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up
Number of subjects: 15
Study 12866763 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 30
Study 12866763 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 30
Study 11678951 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ventilation tubes with adjuvant adenoidectomy
Number of subjects: 506
Study 11678951 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ventilation tubes without adjuvant adenoidectomy
Number of subjects: 506
Study 11678951 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical management
Number of subjects: 506
Study 11678951 — intervention group
Group type: COMPARATOR
Intervention: Not recruited due to overriding concern
Number of subjects: 506
Study 11678951 — intervention group
Group type: COMPARATOR
Intervention: Not randomized due to overriding concern
Number of subjects: 506
Study 11678951 — intervention group
Group type: COMPARATOR
Intervention: Not randomized due to parental refusal
Number of subjects: 506
Study 9751327 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 0
Study 9751327 — intervention group
Group type: COMPARATOR
Intervention: Observation (control)
Number of subjects: 0
Study 7932990 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms based on BPD, AC, and FL
Number of subjects: 243
Study 7932990 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms based on gestational age and transverse cerebellar diameter
Number of subjects: 243
Study 7932990 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms based on transverse cerebellar diameter
Number of subjects: 243
Study 7932990 — intervention group
Group type: COMPARATOR
Intervention: Normal fetuses
Number of subjects: 243
Study 3063479 — intervention group
Group type: EXPERIMENTAL
Intervention: KCl 20 mEq/65 ml iv with lidocaine 50 mg
Number of subjects: 18
Study 3063479 — intervention group
Group type: COMPARATOR
Intervention: KCl 20 mEq/65 ml iv without lidocaine
Number of subjects: 18
Study 29672578 — intervention group
Group type: EXPERIMENTAL
Intervention: MHC (manual, handover meeting, and three site visits)
Number of subjects: 0
Study 29672578 — intervention group
Group type: EXPERIMENTAL
Intervention: MH (manual plus handover meeting)
Number of subjects: 0
Study 29672578 — intervention group
Group type: EXPERIMENTAL
Intervention: M (written manual only)
Number of subjects: 0
Study 26585585 — intervention group
Group type: EXPERIMENTAL
Intervention: ADSCs with fibrin glue and microfracture (MFX)
Number of subjects: 80
Study 26585585 — intervention group
Group type: COMPARATOR
Intervention: Microfracture (MFX) alone
Number of subjects: 80
Study 25591431 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI (pleth variability index) monitoring during passive leg raising (PLR) test
Number of subjects: 87
Study 25591431 — intervention group
Group type: EXPERIMENTAL
Intervention: SVV (stroke volume variation) monitoring during passive leg raising (PLR) test
Number of subjects: 87
Study 23602769 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 1391
Study 23602769 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1391
Study 20722026 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxcinod 750 mg twice daily
Number of subjects: 810
Study 20722026 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 810
Study 20722026 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen 500 mg twice daily
Number of subjects: 810
Study 20722026 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxcinod
Number of subjects: 810
Study 20722026 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen
Number of subjects: 810
Study 18685062 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at -40 mmHg
Number of subjects: 0
Study 18685062 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at -15 mmHg
Number of subjects: 0
Study 18685062 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor stress (CPT)
Number of subjects: 0
Study 18685062 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin supplementation
Number of subjects: 0
Study 16779846 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchofiberscopes
Number of subjects: 10
Study 16779846 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchovideoscopes
Number of subjects: 10
Study 16779846 — intervention group
Group type: COMPARATOR
Intervention: Comparison of bronchofiberscopes and bronchovideoscopes
Number of subjects: 10
Study 14673038 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen plus low-dose prednisone (p+T) for 12 months
Number of subjects: 320
Study 14673038 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant therapy
Number of subjects: 320
Study 10783220 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide therapy
Number of subjects: 9461
Study 10783220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9461
Study 8836829 — intervention group
Group type: EXPERIMENTAL
Intervention: Information designed to increase anxiety about health
Number of subjects: 82
Study 8836829 — intervention group
Group type: EXPERIMENTAL
Intervention: Information designed to decrease anxiety about health
Number of subjects: 82
Study 1460170 — intervention group
Group type: EXPERIMENTAL
Intervention: Global self‐ratings administered twice a day
Number of subjects: 37
Study 1460170 — intervention group
Group type: EXPERIMENTAL
Intervention: Itemized, prospective, observer‐rated scale administered twice a day
Number of subjects: 37
Study 1460170 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospective item on the Hamilton Depression Rating Scale
Number of subjects: 37
Study 1460170 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical diurnal variation (mood worsening in the evening)
Number of subjects: 37
Study 1460170 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical diurnal variation (mood worsening in the morning)
Number of subjects: 37
Study 30744529 — intervention group
Group type: EXPERIMENTAL
Intervention: AET+UC
Number of subjects: 57
Study 30744529 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 57
Study 27541314 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-delivered maintenance intervention based on acceptance and commitment therapy (ACT)
Number of subjects: 48
Study 27034176 — intervention group
Group type: EXPERIMENTAL
Intervention: Upfront EGFR‐TKI followed by SRS or WBRT
Number of subjects: 50
Study 27034176 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT then EGFR‐TKI
Number of subjects: 50
Study 27034176 — intervention group
Group type: EXPERIMENTAL
Intervention: SRS followed by EGFR‐TKI
Number of subjects: 50
Study 27034176 — intervention group
Group type: COMPARATOR
Intervention: Upfront EGFR‐TKI
Number of subjects: 50
Study 27034176 — intervention group
Group type: COMPARATOR
Intervention: Upfront RT (WBRT or SRS)
Number of subjects: 50
Study 27034176 — intervention group
Group type: EXPERIMENTAL
Intervention: Upfront RT
Number of subjects: 50
Study 25127659 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron 0.075 mg
Number of subjects: 220
Study 25127659 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron 4 mg
Number of subjects: 220
Study 22374684 — intervention group
Group type: EXPERIMENTAL
Intervention: THIN hospitalization documentation
Number of subjects: 60
Study 22374684 — intervention group
Group type: EXPERIMENTAL
Intervention: THIN-documented pneumonia admission
Number of subjects: 60
Study 22374684 — intervention group
Group type: EXPERIMENTAL
Intervention: THIN hospitalization dates
Number of subjects: 60
Study 22374684 — intervention group
Group type: EXPERIMENTAL
Intervention: THIN admission date
Number of subjects: 60
Study 20204974 — intervention group
Group type: COMPARATOR
Intervention: CAD-only (n = 30)
Number of subjects: 91
Study 20204974 — intervention group
Group type: COMPARATOR
Intervention: CAD plus an additional four-session self-management group training (CAD+G, n = 31)
Number of subjects: 91
Study 20204974 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlist, n = 30)
Number of subjects: 91
Study 17397910 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin/paclitaxel or carboplatin/paclitaxel (exact dosage not specified)
Number of subjects: 761
Study 17397910 — intervention group
Group type: COMPARATOR
Intervention: Surgery in centers with comprehensive surgical debulking including retroperitoneal lymphadenectomy and peritoneal stripping
Number of subjects: 761
Study 17397910 — intervention group
Group type: COMPARATOR
Intervention: Higher pre-operative tumor load
Number of subjects: 761
Study 17397910 — intervention group
Group type: COMPARATOR
Intervention: Higher FIGO stage
Number of subjects: 761
Study 17397910 — intervention group
Group type: COMPARATOR
Intervention: Worse performance status
Number of subjects: 761
Study 17397910 — intervention group
Group type: COMPARATOR
Intervention: Advanced age
Number of subjects: 761
Study 17397910 — intervention group
Group type: COMPARATOR
Intervention: Presence of peritoneal carcinomatosis
Number of subjects: 761
Study 17397910 — intervention group
Group type: COMPARATOR
Intervention: Post-operative residual tumor
Number of subjects: 761
Study 17397910 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive primary surgery and complete debulking
Number of subjects: 761
Study 15674097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous esomeprazole 40 mg
Number of subjects: 64
Study 15674097 — intervention group
Group type: COMPARATOR
Intervention: Oral esomeprazole 40 mg
Number of subjects: 64
Study 15674097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous esomeprazole 20 mg
Number of subjects: 64
Study 15674097 — intervention group
Group type: COMPARATOR
Intervention: Oral esomeprazole 20 mg
Number of subjects: 64
Study 15674097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous esomeprazole (both dosages)
Number of subjects: 64
Study 15674097 — intervention group
Group type: COMPARATOR
Intervention: Oral esomeprazole (both dosages)
Number of subjects: 64
Study 15674097 — intervention group
Group type: EXPERIMENTAL
Intervention: Both administration routes
Number of subjects: 64
Study 12568187 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic vertical banded gastroplasty (LVBG)
Number of subjects: 30
Study 12568187 — intervention group
Group type: COMPARATOR
Intervention: Open vertical banded gastroplasty (OVBG)
Number of subjects: 30
Study 10450410 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire A
Number of subjects: 467
Study 10450410 — intervention group
Group type: COMPARATOR
Intervention: Questionnaire B
Number of subjects: 467
Study 10450410 — intervention group
Group type: COMPARATOR
Intervention: Dietary history interview
Number of subjects: 467
Study 8576661 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide 1 mg/kg immediate preoperation
Number of subjects: 90
Study 8576661 — intervention group
Group type: COMPARATOR
Intervention: Control (no furosemide)
Number of subjects: 90
Study 8576661 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide group
Number of subjects: 90
Study 8576661 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 1970960 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain tablets (500 mg theophylline)
Number of subjects: 6